These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 22117627)
1. Histo-blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease. Yamamura K; Ihara K; Ikeda K; Nagata H; Mizuno Y; Hara T Int J Immunogenet; 2012 Apr; 39(2):119-25. PubMed ID: 22117627 [TBL] [Abstract][Full Text] [Related]
2. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. Nishimura S; Zaitsu M; Hara M; Yokota G; Watanabe M; Ueda Y; Imayoshi M; Ishii E; Tasaki H; Hamasaki Y J Pediatr; 2003 Sep; 143(3):357-62. PubMed ID: 14517520 [TBL] [Abstract][Full Text] [Related]
3. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Kariyazono H; Ohno T; Khajoee V; Ihara K; Kusuhara K; Kinukawa N; Mizuno Y; Hara T Pediatr Res; 2004 Dec; 56(6):953-9. PubMed ID: 15470196 [TBL] [Abstract][Full Text] [Related]
4. Association of COL11A2 polymorphism with susceptibility to Kawasaki disease and development of coronary artery lesions. Sheu JJ; Lin YJ; Chang JS; Wan L; Chen SY; Huang YC; Chan C; Chiu IW; Tsai FJ Int J Immunogenet; 2010 Dec; 37(6):487-92. PubMed ID: 20618517 [TBL] [Abstract][Full Text] [Related]
5. [Relationship between fibrinogen Bß-148C/T polymorphism and coronary artery lesions in children with Kawasaki disease]. Gao J; Wang HY; Wu NJ; Zhang SH Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jul; 12(7):518-20. PubMed ID: 20637145 [TBL] [Abstract][Full Text] [Related]
6. Genetic variations of HLA-DRB1 and susceptibility to Kawasaki disease in Taiwanese children. Huang FY; Chang TY; Chen MR; Hsu CH; Lee HC; Lin SP; Kao HA; Chiu NC; Chi H; Liu TY; Liu HF; Dang CW; Chu CC; Lin M; Sung TC; Lee YJ Hum Immunol; 2007 Jan; 68(1):69-74. PubMed ID: 17207714 [TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease. Ikeda K; Ihara K; Yamaguchi K; Muneuchi J; Ohno T; Mizuno Y; Hara T Pediatr Res; 2008 Feb; 63(2):182-5. PubMed ID: 18091353 [TBL] [Abstract][Full Text] [Related]
8. HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms. Lin YJ; Wan L; Wu JY; Sheu JJ; Lin CW; Lan YC; Lai CH; Hung CH; Tsai Y; Tsai CH; Lin TH; Lin JG; Hsueh KC; Huang YM; Chang JS; Tsai FJ Arthritis Rheum; 2009 Feb; 60(2):604-10. PubMed ID: 19180512 [TBL] [Abstract][Full Text] [Related]
9. The -590 C/T and 8375 A/G interleukin-4 polymorphisms are not associated with Kawasaki disease in Taiwanese children. Huang FY; Chang TY; Chen MR; Lee HC; Chiu NC; Chi H; Hsu CH; Lin SP; Liu HF; Chen WF; Chu CC; Lin M; Lee YJ Hum Immunol; 2008 Jan; 69(1):52-7. PubMed ID: 18295676 [TBL] [Abstract][Full Text] [Related]
14. [Expression of monocyte chemotactic protein-1 in peripheral blood mononuclear cells of children with Kawasaki disease and its relation to coronary artery impairment]. Zhang J; Gui YH; Yang Y Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):132-5. PubMed ID: 19099689 [TBL] [Abstract][Full Text] [Related]
15. Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. Park JA; Shin KS; Kim YW J Korean Med Sci; 2005 Aug; 20(4):607-11. PubMed ID: 16100452 [TBL] [Abstract][Full Text] [Related]
16. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Quasney MW; Bronstein DE; Cantor RM; Zhang Q; Stroupe C; Shike H; Bastian JF; Matsubara T; Fujiwara M; Akimoto K; Newburger JW; Burns JC Pediatr Res; 2001 May; 49(5):686-90. PubMed ID: 11328953 [TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class I chain-related gene polymorphisms: associated with susceptibility to Kawasaki disease and coronary artery aneurysms. Hsieh YY; Chang CC; Hsu CM; Chen SY; Lin WH; Tsai FJ Genet Test Mol Biomarkers; 2011 Nov; 15(11):755-63. PubMed ID: 21815799 [TBL] [Abstract][Full Text] [Related]
18. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway. Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052 [TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement. Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708 [TBL] [Abstract][Full Text] [Related]
20. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease. Ahn JG; Bae Y; Shin D; Nam J; Kim KY; Kim DS Rheumatology (Oxford); 2019 May; 58(5):770-775. PubMed ID: 30535242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]